Shenzhen Neptunus Interlong Bio Technique Co
Shenzhen Neptunus Interlong Bio Technique Co., often referred to as Neptunus, is a leading player in the biotechnology industry, headquartered in Shenzhen, China. Founded in 1995, the company has established a strong presence in various operational regions, focusing on the development and production of innovative biopharmaceuticals and medical devices. Neptunus is renowned for its core products, which include advanced biopharmaceuticals and diagnostic reagents, distinguished by their high quality and efficacy. The company has achieved significant milestones, including numerous certifications and partnerships that underscore its commitment to excellence in research and development. With a robust market position, Neptunus continues to contribute to the global healthcare landscape, driven by a dedication to innovation and quality in biotechnology solutions.
DitchCarbon Score
How does Shenzhen Neptunus Interlong Bio Technique Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shenzhen Neptunus Interlong Bio Technique Co's score of 2 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shenzhen Neptunus Interlong Bio Technique Co's reported carbon emissions
In 2022, Shenzhen Neptunus Interlong Bio Technique Co reported total carbon emissions of approximately 10,226,000 kg CO2e, comprising about 4,515,000 kg CO2e from Scope 1 and about 10,226,000 kg CO2e from Scope 2 emissions. This marked an increase from 2021, where total emissions were about 8,117,000 kg CO2e, with Scope 1 emissions at approximately 4,342,000 kg CO2e. In 2020, the company recorded total emissions of about 11,242,000 kg CO2e, with Scope 1 emissions at approximately 4,094,000 kg CO2e and Scope 2 emissions at about 7,148,000 kg CO2e. Despite these figures, Shenzhen Neptunus Interlong Bio Technique Co has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or Science-Based Targets Initiative (SBTi) commitments suggests that the company may still be in the early stages of formalising its climate strategy. As the industry increasingly prioritises sustainability, it will be crucial for the company to establish clear commitments to reduce emissions and enhance its environmental performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 4,094,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 7,148,000 | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shenzhen Neptunus Interlong Bio Technique Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
